Cargando…

Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center

INTRODUCTION: After the first case of Covid-19 was identified in Wuhan City, China, the numbers increased rapidly all over the world putting a huge burden on the entire healthcare system. Managing these cases posed a great challenge to the treating clinicians in the absence of targeted therapy. At t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohanty, Bijaya, Sunder, Ashok, Satyanarayan, Bhagyalakshmi, Kumar, Manish, Shukla, Rajiv, Ahmed, Asif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797123/ https://www.ncbi.nlm.nih.gov/pubmed/35136795 http://dx.doi.org/10.4103/jfmpc.jfmpc_578_21

Ejemplares similares

Late onset crohns ileitis—A diagnostic dilemma
por: Sunder, Ashok, et al.
Publicado: (2022)

Picking up an insulinoma – The challenges ahead
por: Sunder, Ashok, et al.
Publicado: (2022)

Clinicolaboratory profile of expanded dengue syndrome – Our experience in a teaching hospital
por: Mohanty, Bijaya, et al.
Publicado: (2019)

Clinical and epidemiological profile of snakebite cases – A study from an industrial teaching hospital at Jamshedpur, Jharkhand, India
por: Satyanarayan, Bhagyalakshmi, et al.
Publicado: (2022)

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
por: Rosas, Ivan O., et al.
Publicado: (2021)

Lupus myocarditis-A rare case
por: Mohanty, Bijaya, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Remdesivir/tocilizumab: Endogenous endophthalmitis: 3 case reports
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Various toxicities: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy: case report
Publicado: (2022)

Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia
por: Jamir, Imtiakum, et al.
Publicado: (2020)

Use of tocilizumab, remdesivir, and high-dose methylprednisolone prevents intubation in an ESRD patient with COVID-19 pneumonia
por: Judge, Ramzan, et al.
Publicado: (2022)

Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
por: Vulturar, Damiana-Maria, et al.
Publicado: (2022)

Remdesivir vs tocilizumab in COVID-19: adverse event profiles
Publicado: (2021)

Kounis syndrome: A rare case
por: Sunder, Ashok, et al.
Publicado: (2020)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Double-outlet left ventricle: A rare case
por: Sunder, Ashok, et al.
Publicado: (2019)

Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Rhabdomyolysis - Exercise induced nightmare
por: Sunder, Ashok, et al.
Publicado: (2019)

Immune Thrombocytopenia Secondary to COVID-19 in a Vitamin B12-Deficient Patient: A Diagnostic Dilemma and Therapeutic Challenge
por: Bijaya, Mohanty, et al.
Publicado: (2023)

Cold agglutinin-induced hemolytic anemia as the primary presentation in SLE - A case report
por: Mohanty, Bijaya, et al.
Publicado: (2019)

Remdesivir/tocilizumab: Rebound of HCV viral load and loss of anti-HBs: case report
Publicado: (2021)

The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis
por: Sodani, Pietro, et al.
Publicado: (2020)

Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
por: Magyari, Ferenc, et al.
Publicado: (2022)

Comparative Safety and Efficacy of Remdesivir Versus Remdesivir Plus Convalescent Plasma Therapy (CPT) and the Effect of Timing of Initiation of Remdesivir in COVID-19 Patients: An Observational Study From North East India
por: Sharma, Dibya J, et al.
Publicado: (2021)

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report
Publicado: (2020)

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)

The Role of Convalescent Plasma and Tocilizumab in the Management of COVID-19 Infection: A Cohort of 110 Patients from a Tertiary Care Hospital in Oman
por: Khamis, Faryal, et al.
Publicado: (2021)

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma
por: Iaboni, Aled, et al.
Publicado: (2021)

Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical Analysis
por: Voit, Katja, et al.
Publicado: (2021)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia
por: Basheer, Maamoun, et al.
Publicado: (2021)

Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya
por: Shah, Reena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_34jo1stmc9b0ndktnaljho6k10